Fenfluramine clinical trials
Also written Fintepla and ZX008.
How each study uses Fenfluramine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Fenfluramine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 25 Jun 2020 · FINTEPLA · NDA 212102 (FDA, Drugs@FDA)
- European Union
- 18 Dec 2020 · Fintepla · EMEA/H/C/003933 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
21 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 11
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. (6) · UCB BIOSCIENCES, Inc. (3) · Zogenix, Inc. (2) · KU Leuven (1) · Hospital Ruber Internacional (1) · Elizabeth Anne Thiele (1) · NYU Langone Health (1) · University of Oxford (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4, 1 in phase 3
Studies that test Fenfluramine, phase 3 first.
- Nov 2027A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.Phase 3 · Zogenix, Inc.
- Dec 2026Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of AgePhase 4 · University of Colorado, Denver
- Dec 2026Treatment of Refractory Infantile Spasms With FenfluraminePhase 2 · Children's Hospital of Orange County
- Sep 2027The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome ProjectPhase 4 · The University of Texas Health Science Center, Houston
Studies
Open first, then newest update. How each study uses Fenfluramine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 22
- A Phase 3 Study of Fenfluramine Hydrochloride in Rett SyndromeRecruitingPhase 3UCB BIOSCIENCES, Inc.NCT07503444Written as fenfluramine hydrochloride
- The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome ProjectRecruitingPhase 4The University of Texas Health Science Center, HoustonNCT07112365Written as Fenfluramine treatment (Fintepla)
- Using Fenfluramine to Test the Serotonin Deficiency Theory of DepressionNot yet recruitingNot applicableImperial College Healthcare NHS TrustNCT07651293Written as Fenfluramine Hydrochloride
- Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of AgeRecruitingPhase 4University of Colorado, DenverNCT06598449Written as fenfluramine
- Treatment of Refractory Infantile Spasms With FenfluramineRecruitingPhase 2Children's Hospital of Orange CountyNCT04289467Written as Fenfluramine
- Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut EpilepsyCompletedPhase 2KU LeuvenNCT02655198Written as Fenfluramine
- Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic OutcomesCompletedPhase 4Hospital Ruber InternacionalNCT05232630Written as Fenfluramine
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet SyndromeCompletedPhase 3UCB BIOSCIENCES, Inc.NCT06118255Written as fenfluramine
- A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study ParticipantsCompletedPhase 1UCB BIOSCIENCES, Inc.NCT06679413Written as fenfluramine HCl
- Fenfluramine for Adult Dravet PatientsTerminatedPhase 3University Health Network, TorontoNCT05560282Written as Fenfluramine
- A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.Active, not recruitingPhase 3Zogenix, Inc.NCT05064878Written as Fenfluramine
- A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut SyndromeCompletedPhase 3Zogenix, Inc.NCT03936777Written as ZX008 (Fenfluramine Hydrochloride)
- An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet SyndromeCompletedPhase 3Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.NCT02823145Written as ZX008 (Fenfluramine Hydrochloride)
- A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut SyndromeCompletedPhase 3Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.NCT03355209Written as ZX008 0.2 or 0.8 mg/kg/day
- Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).CompletedPhase 3Elizabeth Anne ThieleNCT03790137Written as Fenfluramine Hydrochloride
- A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking CannabidiolCompletedPhase 1Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.NCT03467113Written as ZX008 0.2 to 0.8 mg/kg/day
- A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet SyndromeTerminatedPhase 3Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.NCT03299842Written as ZX008 (Fenfluramine Hydrochloride)
- Fenfluramine in CDKL5 Deficiency Disorder (CDD)CompletedPhase 2NYU Langone HealthNCT03861871Written as Fenfluramine Hydrochloride
- A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet SyndromeCompletedPhase 3Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.NCT02682927Written as ZX008 (Fenfluramine Hydrochloride)
- Fenfluramine and CognitionCompletedPhase 4University of OxfordNCT05026398Written as Fenfluramine
Codes
What other systems call Fenfluramine · ClinicalTrials.gg INT007480
- MeSH (NLM) D005277FenfluramineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2DS058H2CFFENFLURAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 4328Confirmed FDA, Wikidata
- Wikidata Q418928(RS)-fenfluramineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81418FenfluramineOne source FDA
- DrugBank DB00574One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005277 | Fenfluramine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2DS058H2CF | FENFLURAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 4328 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418928 | (RS)-fenfluramine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81418 | Fenfluramine | One source FDA |
| DrugBank | DB00574 | — | One source Wikidata |
Also registered as fenfluramine hydrochloride (UNII 3KC089243P · RxNorm 82018).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.